News

Curative Potential of Neoadjuvant Denosumab in the Treatment of Giant Cell Spinal Tumor? A Case Study

9. 4. 2022 Source: Prevention of Bone Events

Portuguese authors present a case study of a young woman diagnosed with a giant cell spinal tumor who achieved complete histological remission following denosumab treatment.

Prevention of Skeletal Events in the Therapy of Patients with Advanced Prostate Cancer

Prostate cancer most commonly forms metastases in the bones. In patients with this advanced disease, skeletal events occur, negatively affecting their quality of life. Zoledronic acid and denosumab…

9. 4. 2022 Source: Prevention of Bone Events

The Immune System in the Pathophysiology of ITP

From the perspective of the pathophysiology of immune thrombocytopenia (ITP), it appears that the etiology of this disease is very complex and involves both antibody and cellular immunity.

9. 4. 2022 Source: Immune Thrombocytopenia

Over 10 Years of Experience with TPO-RA in the Treatment of Immune Thrombocytopenia

Medications from the group of thrombopoietin receptor agonists (TPO-RA) have become an integral part of the therapy for patients with immune thrombocytopenia (ITP) over the past more than 10 years.…

9. 4. 2022 Source: Immune Thrombocytopenia

Anticoagulation Therapy in Patients on ECMO During the COVID-19 Pandemic

In the past 2 years, the use of extracorporeal membrane oxygenation (ECMO) in intensive care units (ICU) has increased in connection with the treatment of severe COVID-19 pneumonia. Dr. Pilar Marcos…

8. 4. 2022 Source: Life-threatening Bleeding

Can Erdostein Help in Treating Infections Related to Biofilm Formation?

One of the reasons for the very difficult treatment of diseases caused by resistant bacterial strains is the significant ability of these infection-causing agents to form biofilms. What exactly is a…

8. 4. 2022 Source: Cough Therapy

hospitalizovaná pacienta covid nemocnice péče

Administration of Erdosteine After Severe Course of COVID-19 in the Early Period After Patient Discharge From Medical Facility

Erdosteine is a mucomodulatory drug used in the therapy of various acute and chronic respiratory diseases. Its mechanism of action is considered complex based on available evidence, encompassing…

8. 4. 2022 Source: Cough Therapy

Even a Single Epileptic Seizure is Too Much

Focal epileptic seizures resistant to pharmacotherapy represent an ongoing unmet medical need.

7. 4. 2022 Source: Epilepsy

Insufficiently Controlled Epilepsy Reduces Quality and Length of Life

The effects of uncontrolled epilepsy far exceed the moment of a seizure, having a substantial impact on the psychological and physical well-being of patients. These individuals often sustain injuries…

7. 4. 2022 Source: Epilepsy

Clinical and Microbiological Effect of L. reuteri in the Treatment of Chronic Periodontitis

The Journal of Clinical Periodontology published the results of a study evaluating the effect of the probiotic bacterial strain Lactobacillus reuteri as an adjunctive treatment for chronic…

6. 4. 2022 Source: GI, colic and microbiome

How to Detect COPD Early in Primary Care?

Chronic obstructive pulmonary disease (COPD) can be present even in individuals without obvious subjective symptoms, or the emerging symptoms may be overlooked by both the patient and the doctor due…

6. 4. 2022 Source: Treatment of Asthma and COPD

News in COPD Treatment Recommendations in a Nutshell

We present an overview of the most important changes in the annually updated recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

6. 4. 2022 Source: Treatment of Asthma and COPD

STADA Brings Innovative Drug for Treatment of Advanced Parkinson's Disease to Czech Republic

STADA PHARMA CZ is introducing a new system for continuous delivery of 3 active substances for the treatment of advanced stages of Parkinson's disease (PD) to the Czech market. It is one of the major…

6. 4. 2022 Source: Parkinson's Disease

Optimization of Enoxaparin Dosing in Obese Patients

Obesity is a risk factor for venous thromboembolism; however, there is uncertainty regarding the optimal dose of enoxaparin for treating acute episodes in the obese population. Two observational…

4. 4. 2022 Source: Thromboprophylaxis

Enoxaparin in the Treatment of Pulmonary Embolism in a Morbidly Obese Patient –⁠ Case Report

The number of patients suffering from overweight and obesity has been steadily increasing in recent years. Obesity is one of the independent risk factors for thromboembolic disease. Treating…

4. 4. 2022 Source: Thromboprophylaxis

1 … 56 57 58 59 60 … 115

Back Filter by speciality

Remove filters

Popular this week